Session 2: Microbiome and gut-liver diseases

‘The gut liver axis during early life’

By Lukas C. Bossert|2022-08-31T00:03:46+02:0001.07.2022|

Read More

‘Causality or association of gutmicrobiota and their metabolites in human NAFLD-NASH;  potential for  new diagnostic and therapeutic leads’

By Lukas C. Bossert|2022-07-01T15:51:39+02:0001.07.2022|

Read More

‘Exploring the gut-liver axis in cancer cachexia’

By Lukas C. Bossert|2022-07-01T15:50:20+02:0001.07.2022|

Read More

‘Short-chain fatty acids and advanced chronic liver disease’

By Lukas C. Bossert|2022-07-01T15:47:25+02:0001.07.2022|

Read More

‘Modulation of the Gut-Liver Axis through Fecal Microbiota Transfer’

By Lukas C. Bossert|2022-07-01T15:47:41+02:0001.07.2022|

Read More